BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33135475)

  • 1. The Prognostic Value of the Prognostic Nutritional Index (PNI) in Radically Resected Esophagogastric Junction Adenocarcinoma.
    Ge K; Fang C; Zhu D; Yan H; Wang Q; Chen W; Wu J
    Nutr Cancer; 2021; 73(11-12):2589-2596. PubMed ID: 33135475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of preoperative inflammation-based prognostic scores and nutritional status for overall survival in resected patients with nonmetastatic Siewert type II/III adenocarcinoma of esophagogastric junction.
    Zhang L; Su Y; Chen Z; Wei Z; Han W; Xu A
    Medicine (Baltimore); 2017 Jul; 96(30):e7647. PubMed ID: 28746229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Prognostic Abilities Among Preoperative Laboratory Data Indices in Patients with Resectable Gastric and Esophagogastric Junction Adenocarcinoma.
    Urabe M; Yamashita H; Watanabe T; Seto Y
    World J Surg; 2018 Jan; 42(1):185-194. PubMed ID: 28741195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative pre-albumin predicts prognosis of patients after gastrectomy for adenocarcinoma of esophagogastric junction.
    Han WX; Chen ZM; Wei ZJ; Xu AM
    World J Surg Oncol; 2016 Nov; 14(1):279. PubMed ID: 27809860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
    [No Abstract]   [Full Text] [Related]  

  • 6. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
    Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph Node Ratio Is an Independent Prognostic Factor for Patients with Siewert Type II Adenocarcinoma of Esophagogastric Junction: Results from a 10-Year Follow-up Study.
    Zhang Y; Liu D; Zeng D; Chen C
    J Gastrointest Cancer; 2021 Sep; 52(3):983-992. PubMed ID: 32954465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of preoperative albumin-to-globulin ratio and prognostic nutritional index combined score in Siewert type 3 adenocarcinoma of esophagogastric junction.
    Wang Y; Zhu Z; Li C; Ma Y; You Q; Li Z; Zhang H; Song H; Xue Y
    Cancer Manag Res; 2019; 11():7631-7638. PubMed ID: 31616179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
    Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the superiority of different TNM staging systems in Siewert III adenocarcinoma of esophagogastric junction].
    Lu Y; Xi H; Xie T; Qiu Z; Wang X; Wei B; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):143-148. PubMed ID: 30799536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of preoperative monocyte-lymphocyte ratio on prognosis of patients with resectable esophagogastric junction cancer].
    Zhou WJ; Wu J; Li XD; Wang Q; Ni XF; Jiang JT; Ji M; Wu CP
    Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):178-183. PubMed ID: 28316215
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
    Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the value of 7th editions of UICC-AJCC esophageal and gastric cancer TNM staging systems for prognostic prediction of adenocarcinoma of esophagogastric junction (Siewert type II)].
    Shi GD; Luo ZL; Fu MY; Tian D; Zhang L; Zhang KP
    Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):916-21. PubMed ID: 25623766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data.
    Chen J; Xia YJ; Liu TY; Lai YH; Yu JS; Zhang TH; Ooi S; He YL
    BMC Cancer; 2021 May; 21(1):532. PubMed ID: 33971833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic nutritional index is a prognostic factor for patients with gastric cancer and esophagogastric junction cancer undergoing proximal gastrectomy with esophagogastrostomy by the double-flap technique: A secondary analysis of the rD-FLAP study.
    Kakiuchi Y; Kuroda S; Choda Y; Otsuka S; Ueyama S; Tanaka N; Muraoka A; Hato S; Kamikawa Y; Fujiwara T
    Surg Oncol; 2023 Oct; 50():101990. PubMed ID: 37717376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes and prognostic factor analysis of resected Siewert type II adenocarcinoma of esophagogastric junction in China: a seven-year study.
    Feng Y; Jiang Y; Zhao Q; Liu J; Zhang H; Chen Q
    BMC Surg; 2020 Nov; 20(1):302. PubMed ID: 33256690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer.
    Kudou K; Saeki H; Nakashima Y; Kamori T; Kawazoe T; Haruta Y; Fujimoto Y; Matsuoka H; Sasaki S; Jogo T; Hirose K; Hu Q; Tsuda Y; Kimura K; Ando K; Oki E; Ikeda T; Maehara Y
    J Gastroenterol Hepatol; 2019 Feb; 34(2):355-363. PubMed ID: 30119141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of survival and prognosis of Siewert Ⅱ/Ⅲ esophagogastric junction adenocarcinoma patients with non-operative acute upper gastrointestinal hemorrhage].
    Tian L; Yu L
    Zhonghua Yi Xue Za Zhi; 2020 Jun; 100(24):1881-1885. PubMed ID: 32575932
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical study on two reconstruction methods of proximal gastrectomy and piggyback jejunal interposition for Siewert Ⅱ or Ⅲ adenocarcinoma of esophagogastric junction].
    Xu N; Dong JH; Zhang WH; Tao K; Huang QX; Li ZG; Zong L
    Zhonghua Wai Ke Za Zhi; 2019 Feb; 57(2):114-118. PubMed ID: 30704214
    [No Abstract]   [Full Text] [Related]  

  • 20. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
    Wang JB; Lin MQ; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Huang CM
    Eur J Surg Oncol; 2017 Dec; 43(12):2333-2340. PubMed ID: 28928013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.